Table 1.
MiRNA | Unusual expression | Targets | Function | References |
---|---|---|---|---|
Immune cells | ||||
Th2 cells | ||||
miR-155 | Up | CTLA-4 | Enhances the secretion of IL-4, -5, -13, -17a; enhances mucus secretion; stimulates T-cell activation and proliferative response | [20,27] |
miR-1 | Down | - | Inhibits the secretion of IL-4, -5, -8, TNF-α; regulates Th1/Th2 balance | [25] |
miR-21 | Up | IL-12p35 3ʹUTR | Modulates Th1/Th2 polarization | [31] |
miR-3162-3p | Up | β-catenin | Enhances bronchial hyperresponsiveness and airway inflammation; regulates Th1/Th2 balance | [34] |
miR-1165-3p | Up | IL-13,PPM1A | Inhibits bronchial hyperresponsiveness, airway inflammation, and differentiation of T cells toward Th2 | [35] |
miR-200a /200b | Down | ORMDL3 | Inhibits the secretion of TNF-α, IL-4, -5, -13, and -1β | [36] |
Eosinophils | ||||
miR-30a-3p | Down | CCR3 | Inhibits the secretion of specific IgE, eotaxin-1, IL-5, and IL-4 | [39] |
miR-218-5p | Down | CTNND2 | Inhibits bronchial hyperresponsiveness, eosinophilic airway inflammation, and the expression of CCL26 | [41] |
miR-135b | Down | CXCL12 | Inhibits the immune response of Th17 cells, goblet cell proliferation, and bronchial hyperresponsiveness; reduces the number of eosinophils and lymphocytes | [42] |
miR-135a | Down | The STAT family | Inhibits bronchial hyperresponsiveness and lung pathological changes; reduces the secretion of TNF-α, IL-6, IL-5, and Eotaxin | [43] |
Mast cells | ||||
miR-221 | Up | P27KIP1; PTEN and the p38/NF-κB pathway | Reduces the permeability of inflammatory cells, regulates the cell cycle of mast cells, and promotes their proliferation; increases the secretion of IL-4 and promotes the differentiation of Th cells into Th2 cells | [44–46] |
miRNA-142-3p | Up | LPP | Enhances FceRI-mediated degranulation and rescues the reduction of degranulation |
[47] |
miRNA-126 | Up | DNMT1 | Increases the number of mast cells | [48] |
Neutrophils | ||||
miR-629-3p | Up | IL-8 mRNA | Increases the levels of IL-1β and IL-8 protein, which is positively correlated with the increase of neutrophils in sputum | [49] |
miR-223 | Up | NLRP3 | Inhibits the airway inflammation, NLRP3 level and IL-1β release | [51] |
Macrophages | ||||
miR-142-5p | Up | SOCS1 | Modulates the M2 polarization and profibrotic activities |
[55] |
miR-130a-3p | Down | Proliferator-activated receptor γ | Modulates the M2 polarization and profibrotic activities |
[55] |
Bronchial smooth muscle cells | ||||
miR-26a | Up | GSK-3β | Promotes ASMCs hypertrophy | [57] |
miR-378 | Up | The genes related to ErbB, RAS, MAPK and calcium signaling pathway | Promotes ASMCs proliferation and apoptosis resistance | [59] |
miR-19a | Up | PTEN | Inhibits ASMCs proliferation and migration | [60] |
miR-943-3p | Up | SFRP4 | Increases the number of macrophages, eosinophils, lymphocytes, and neutrophils, increases the expression of collagen, β-catenin, and c-Myc in lung tissue, and promotes subepithelial fibrosis and ASMCs proliferation | [61] |
miR-142 | Down | The genes related to EGFR signaling pathway | Inhibits the proliferation of ASMCs and promotes their apoptosis | [62] |
miR-204-5p | Down | SIX1 | Inhibits ASMCs proliferation and extracellular matrix production | [63] |
Bronchial epithelial cells | ||||
miR-744 | Down | TGF-β1 | Inhibits bronchial epithelial cell proliferation | [119] |
miR-141 | Up | CLCA1 | Stimulates IL-13-induced goblet cell metaplasia, promotes airway remodeling and pathological airway mucus production | [67] |
miR-146a | Up | IRAK1, TRAF6, FOXO3, PDE7A |
Promotes pulmonary mucin deposition, airway remodeling, IgE synthesis, and eosinophilic inflammation | [68,69] |
miR-210 | Down | FOXP3 | Involves in the polarization of Th2 cells | [72] |
miR-34a | Down | The genes related to Wnt signaling pathway | Involves in the polarization of Th2 cells | [72] |